Clinical Research
The dramatic progress that has been made in
treating cancer over the past three decades has
predominantly come from rigid scientific research,
including the testing of new medications and
procedures. These clinical trials are designed
to identify new, more effective therapies. The
patients who participate in these investigative
studies gain access to the very latest changes
in cancer care developed by the nation's foremost
cancer specialists. Only after both governmental
and institutional committees review new treatments
will they be tested in people. This group of
reviewers includes both scientists and non-scientists
who concur on the potential validity of these
studies.
For more information on oncology clinical trials
available at Pennsylvania Hospital, visit Pennsylvania
Oncology Hematology Associates' web site.
Oncology clinical trials are available through
Pennsylvania Oncology Hematology Associates,
the private medical oncology practice. These
include studies that are sponsored by the Eastern
Cooperative Oncology Group (ECOG), the Gynecologic
Oncology Group, the AIDS Malignancy Consortium
and Accelerated Clinical Oncology Research Network
(ACORN). In addition, Phase I, II and II studies
initiated by a number of pharmaceutical organizations
are available.
Patients interested in participating in clinical
research should talk with their doctors. Pennsylvania
Hospital oncologists are leaders in providing
patients access to these new therapeutic modalities.
In addition to the clinical trials conducted
at the Karnell Cancer Center patients have access
to a number of other studies available at the
Abramson Cancer Center.
For more information on clinical trials and
why they are important to the future of cancer
care visit www.nci.nih.gov/clinicaltrials/.
|
